| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00022 | 1 |